IL74642A - Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient - Google Patents

Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient

Info

Publication number
IL74642A
IL74642A IL74642A IL7464285A IL74642A IL 74642 A IL74642 A IL 74642A IL 74642 A IL74642 A IL 74642A IL 7464285 A IL7464285 A IL 7464285A IL 74642 A IL74642 A IL 74642A
Authority
IL
Israel
Prior art keywords
dione
dichloro
methyl
dicyclohexylmethyloxy
9alpha
Prior art date
Application number
IL74642A
Other languages
English (en)
Other versions
IL74642A0 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL74642A0 publication Critical patent/IL74642A0/xx
Publication of IL74642A publication Critical patent/IL74642A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL74642A 1984-04-03 1985-03-19 Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient IL74642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (2)

Publication Number Publication Date
IL74642A0 IL74642A0 (en) 1985-06-30
IL74642A true IL74642A (en) 1988-09-30

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74642A IL74642A (en) 1984-04-03 1985-03-19 Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient

Country Status (16)

Country Link
US (1) US4614736A (pt)
EP (1) EP0161144B1 (pt)
JP (1) JPS60224615A (pt)
AT (1) ATE41604T1 (pt)
AU (1) AU571073B2 (pt)
CA (1) CA1226817A (pt)
DE (1) DE3568944D1 (pt)
DK (1) DK164478C (pt)
FR (1) FR2561919B1 (pt)
GR (1) GR850815B (pt)
HU (1) HU196122B (pt)
IL (1) IL74642A (pt)
MA (1) MA20388A1 (pt)
OA (1) OA07978A (pt)
PT (1) PT80214B (pt)
ZA (1) ZA851927B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
HU196122B (en) 1988-10-28
DK164478B (da) 1992-07-06
ATE41604T1 (de) 1989-04-15
DK146785D0 (da) 1985-04-01
FR2561919A1 (fr) 1985-10-04
AU571073B2 (en) 1988-03-31
IL74642A0 (en) 1985-06-30
FR2561919B1 (fr) 1986-12-19
EP0161144A1 (fr) 1985-11-13
DK146785A (da) 1985-10-04
DE3568944D1 (en) 1989-04-27
AU4080085A (en) 1985-10-10
PT80214A (en) 1985-05-01
DK164478C (da) 1992-11-23
JPS60224615A (ja) 1985-11-09
HUT44436A (en) 1988-03-28
CA1226817A (fr) 1987-09-15
GR850815B (pt) 1985-07-23
EP0161144B1 (fr) 1989-03-22
US4614736A (en) 1986-09-30
OA07978A (fr) 1987-01-31
PT80214B (en) 1987-02-17
MA20388A1 (fr) 1985-10-01
ZA851927B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
IE820207L (en) Aromatic heterocyclic esters of steroids
DE3485647D1 (de) Steroide und diese enthaltende therapeutische zusammensetzungen.
DE3465201D1 (en) 1-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them
PH12415A (en) 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof
AU5323396A (en) Methods of treating inflammation and compositions therefor
IL74642A0 (en) Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient
IL53031A (en) 21-hydroxy(halogen)-17alpha-acyloxy pregna-1,4,8-triene-3,20-diones,their preparation and pharmaceutical compositions containing them
JPS54986A (en) Reducing method of voltage dependancy for fet output capacity
DK92183D0 (da) 11beta-chlor-delta15-steroider, fremgangsmade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
LV5274A3 (lv) 22(R,S)-11 beta,21-dihidroksi-16 alpha,17-butilidenbisoksipregna-1,4-dien-3,20-diona iegusanas panemiens
JPS57175116A (en) Pharmacological composition for circular alopecia treatment and therapy thereby
AR243198A1 (es) Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona
FR2388829A1 (fr) Nouveaux esters de 6-chloro-11b,17a,21-trihydroxy-pregna-1,4,6-triene-3, 20-dione, leur procede de preparation et medicament les contenant
AR243199A1 (es) Procedimiento para elaborar compuestos de 9alfa,21-dihalogeno-llbeta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metil- pregna-1,4-dien-3,20- diona
IE841831L (en) Composition for the treatment of endometriosis based on lhrh¹and progestational agent